Galmed Pharmaceuticals (GLMD) Shares Outstanding (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Shares Outstanding (Entity) of $5914.0 for Q4 2025, up 363.12% year-over-year from $1277.0 in Q4 2024, and down 21.04% quarter-over-quarter from $7490.0 in Q3 2025.
Galmed Pharmaceuticals (GLMD) Shares Outstanding (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $5914.0 for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 363.12% year-over-year to $5914.0; the TTM figure through Dec 2025 stood at $5914.0 (up 363.12% YoY), while the FY2025 annual figure was $5914.0, up 363.12% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $5914.0, down from $7490.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $7490.0 in Q3 2025, with the low at $187.0 in Q4 2021.
- The 5-year median for Shares Outstanding (Entity) is $254.5 (2022), against an average of $1530.4.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) changed 0.0% in 2022, then surged 652.22% in 2025.
- Galmed Pharmaceuticals' Shares Outstanding (Entity) stood at $187.0 in 2021, then rose by 2.67% to $192.0 in 2022, then surged by 65.1% to $317.0 in 2023, then jumped by 302.84% to $1277.0 in 2024, then jumped by 363.12% to $5914.0 in 2025.
- Business Quant data shows GLMD's Shares Outstanding (Entity) at $5914.0 in Q4 2025, $7490.0 in Q3 2025, and $5416.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - | 538,915.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.31 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 3.95 Mn |
| Mar 31, 2025 | 930,822.00 |
| Dec 31, 2024 | 930,822.00 |
| Sep 30, 2024 | 829,500.00 |
| Jun 30, 2024 | 524,541.00 |
| Mar 31, 2024 | 230,786.00 |
| Dec 31, 2023 | 230,786.00 |
| Sep 30, 2023 | 140,014.00 |
| Jun 30, 2023 | 140,014.00 |
| Mar 31, 2023 | 139,676.00 |
| Dec 31, 2022 | 139,676.00 |
| Sep 30, 2022 | 139,375.00 |
| Jun 30, 2022 | 139,375.00 |
| Mar 31, 2022 | 136,648.00 |
| Dec 31, 2021 | 136,648.00 |
| Sep 30, 2021 | 139,356.00 |
| Jun 30, 2021 | 139,356.00 |